Information Provided By:
Fly News Breaks for December 18, 2019
JBL
Dec 18, 2019 | 09:25 EDT
RBC Capital analyst Robert Muller raised his price target on Jabil to $44 after its Q1 earnings beat and raised FY20 guidance. The analyst anticipates continued ramp from the company's Johnson & Johnson Medical Devices Companies partnership generating further sales growth and operating margin expansion. Muller still keeps his Sector Perform rating on Jabil shares however, citing softer than anticipated 5G business and another quarter of "cautious" sentiment in Enterprise.
News For JBL From the Last 2 Days
There are no results for your query JBL